AOD-9604 in Campolide — Fat Loss Peptide Research Guide
AOD-9604 research guide for Campolide. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
For anyone in Campolide searching for AOD-9604, the first thing to know is that this compound is available only through an online research supply market. What this means for Campolide researchers is that physical proximity is irrelevant compared to your ability to verify analytical documentation — and those verification methods are available to every researcher. Separating genuine research-grade AOD-9604 from the rest of the market requires three things: an HPLC chromatogram confirming ≥98% purity, mass spec data establishing the correct molecular weight, and a batch-specific endotoxin panel. This guide takes Campolide researchers through that evaluation process and explains what quality documentation for AOD-9604 should look like.
AOD-9604: What the Research Shows
AOD-9604 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Campolide studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.
Where to Buy AOD-9604 — A Researcher's Guide
Quality AOD-9604 sourcing begins with a straightforward question: does this vendor share complete COA data without being asked? Vendors who do are operating transparently. Endotoxin testing in the COA is critical for any injectable research use — endotoxins from bacterial cell wall components can trigger dangerous inflammatory cascades even at very low concentrations. Positive vendor signals beyond COA quality: established track record of at least two years, knowledgeable support capable of explaining COA data, and temperature-appropriate packaging with desiccant. Bacteriostatic water is the standard reconstitution medium for AOD-9604 — it contains 0.9% benzyl alcohol that prevents microbial contamination and extends reconstituted shelf life to 4 weeks when kept refrigerated.
Order AOD-9604 — ships to Campolide
COA-verified · International tracking · Research grade
All use of AOD-9604 in Campolide or anywhere constitutes research use — this compound is not approved for clinical human use, and all handling should comply with standard research safety practices. Lyophilised AOD-9604 should be frozen at −20°C as soon as it arrives; avoid repeatedly thawing and refreezing reconstituted peptide by preparing small aliquots before storage. Quality AOD-9604 sourcing directly determines safety outcomes — bacterial endotoxin contamination, mislabeling, and degradation products are all safety issues that rigorous vendor evaluation eliminates. The research literature on AOD-9604 should be read critically before designing any protocol — study designs, dosing ranges, and outcome measures vary significantly and not all findings translate directly.
Frequently Asked Questions
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
